Retraction Note: Effects of chronic treatment with the eNOS stimulator Impaza on penis length and sexual behaviors in rats with a high baseline of sexual activity (International Journal of Impotence Research, (2014), 26, 1, (35-40), 10.1038/ijir.2013.12);Effects of chronic treatment with the eNOS stimulator Impaza on penis length and sexual behaviors in rats with a high baseline of sexual activity

International Journal of Impotence Research

Volumn 26, Issue 1, 2014, Pages 35-40

  Chu, X ^a   Zhavbert, E S ^b   Dugina, J L ^b   Kheyfets, I A ^b   Sergeeva, S A ^b   Epstein, O I ^b   Agmo A ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b OOO NPF Materia Medica Holding   (Russian Federation)

Author keywords

Copulatory behavior; Impaza; proerectile drugs; sexual incentive motivation; sildenafil

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMPAZA; SILDENAFIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COPULATION; EJACULATION; FEMALE; LONG TERM CARE; MALE; MALE GENITAL TRACT PARAMETERS; MOTIVATION; NONHUMAN; PENIS; PENIS LENGTH; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR;

ANIMALS; ANTIBODIES; EJACULATION; MALE; MOTIVATION; NITRIC OXIDE SYNTHASE TYPE III; PENILE ERECTION; PENIS; RATS; SEXUAL BEHAVIOR, ANIMAL;

EID: 84892598172     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/s41443-020-0321-x     Document Type: Erratum

References (37)

1. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the Cologne Male Survey. Int J Impot Res 2000; 12: 305-311. (Pubitemid 32175951)
2. Hatzimouratidis K. Epidemiology of male sexual dysfunction. Am J Men's Health 2007; 1: 103-125.
3. McMahon CN, Smith CJ, Shabsigh R. Treating erectile dysfunction when PDE5 inhibitors fail. Br Med J 2006; 332: 589-592. (Pubitemid 44365759)
4. Hackett GI. Patient preferences in treatment of erectile dysfunction: the continuing importance of patient education. Clin Cornerstone Intern 2005; 7: 57-64. (Pubitemid 43071965)
5. Al-Shaiji TF, Brock GB. Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: preference and adherence to treatment. Curr Pharm Design 2009; 15: 3486-3495.
6. Son H, Park K, Kim SW, Paick JS. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Asian J Androl 2004; 6: 117-120. (Pubitemid 38780013)
7. Martyushev-Poklad A, Mazo E, Gamidov S, Dugina J, Epstein O, Sergeeva S. Impaza, an oral antibody therapeutic for erectile dysfunction: benefits from mono-and combined therapy. In: Sae CK, Grootegoed JA, Chemes HE (eds). Proceedings of the VIII International Congress of Andrology. Medimond: Bologna, Italy, pp 49-54, 2005.
8. Mazo EB, Gamidov SE, Ovchinnikov RI. Viagra, Sialis, Impasa-which of them, to whom, when and how? Urologiia 2004; 5: 42-48.
9. Zhavbert ES, Tarasov SA, Dugina JL, Kachanova MV, Sergeeva SA, Epstein OI. The study of the efficacy and safety of Impaza use in erectile dysfunction treatment in patients with different comorbidities: meta-analyses of randomized clinical trials. Proceedings of VII National Scientific Medical Congress. Man's Health, National Institute of Health of the Republic of Armenia, Yerevan, Armenia, 2008, pp 252-253.
10. Gorpintchenko II, Gulaya NM, Miroshnikov YO, Kotzjuruba AB. Impaza in erectile dysfunction therapy: clinical and biochemical aspects. Man's Health 2003; 2: 39-42.
11. Chu X, Ågmo A. Sexual incentive motivation in old male rats: the effects of sildenafil and a compound (Impaza) stimulating endothelial NO synthase. Pharmacol Biochem Behav 2008; 89: 209-217.
12. Chu X, Zhavbert ES, Dugina JL, Kheyfets IA, Sergeeva SA, Epstein OI et al. Sildenafil and a compound stimulating endothelial NO synthase modify sexual incentive motivation and copulatory behavior in male Wistar and Fisher 344 rats. J Sex Med 2008; 5: 2085-2099.
13. Corona G, Mannucci E, Petrone L, Giommi R, Mansani R, Fei L et al. Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction. Int J Impot Res 2004; 16: 275-281. (Pubitemid 38858962)
14. Corona G, Mannucci E, Mansani R, Petrone L, Bartolini M, Giommi R et al. Aging and pathogenesis of erectile dysfunction. Int J Impot Res 2004; 16: 395-402. (Pubitemid 39319038)
15. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35-39. (Pubitemid 40424664)
16. Doherty PC, Bivalacqua TJ, Champion HC, Kadowitz PJ, Greenwood-Van Meerveld B, Berzetei-Gurske I et al. Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats. J Urol 2001; 165: 1004-1009. (Pubitemid 32156339)
17. 1 and rolipram, a selective inhibitor of the type 4 phosphodies-terase (PDE 4). J Urol 1999; 162: 1848-1855. (Pubitemid 29474740)
18. Giuliano F, Bernabé J, Rampin O, Courtois F, Benoit G, Rosseau JP. Telemetric monitoring of intracavernous pressure in freely moving rats during copulation. J Urol 1994; 152: 1271-1274. (Pubitemid 24283496)
19. Bernabé J, Rampin O, Sachs BD, Giuliano F. Intracavernous pressure during erection in rats: an integrative approach based on telemetric recording. Am J Physiol 1999; 45: R441-R449. (Pubitemid 29098679)
20. Giuliano F, Rossler AS, Clement P, Droupy S, Alexandre L, Bernabé J. The use of telemetry technology to test the proerectile effect of melanotan-II (MT-II) in conscious rats. Eur Urol 2005; 48: 145-152.
21. Ågmo A. Unconditioned sexual incentive motivation in the male Norway rat (Rattus norvegicus). J Comp Psychol 2003; 117: 3-14. (Pubitemid 37177362)
22. Ågmo A, Turi AL, Ellingsen E, Kaspersen H. Preclinical models of sexual desire: conceptual and behavioral analyses. Pharmacol Biochem Behav 2004; 78: 379-404. (Pubitemid 38901007)
23. Ågmo A. Male rat sexual behavior. Brain Res Protoc 1997; 1: 203-209. (Pubitemid 28281344)
24. Natali A, Bartolini M, Lucarini S, Vignolini G, Nelli F, Menchi I. Statistical evaluation of hemodynamic effects of regular use of sildenafil on the human corpora cavernosa. Urol Int 2009; 82: 53-60.
25. Lowy M, Collins S, Bloch M, Gillman M, Lording D, Sutherland P et al. Quality of Erection Questionnaire correlates: change in erection quality with erectile function, hardness, and psychosocial measures in men treated with sildenafil for erectile dysfunction. J Sex Med 2007; 4: 83-92. (Pubitemid 46002370)
26. Holmes GM, Chapple WD, Leipheimer RE, Sachs BD. Electromyographic analysis of male rat perineal muscles during copulation and reflexive erections. Physiol Behav 1991; 49: 1235-1246.
27. Sachs BD. Role of striatal penile muscles in penile reflexes, copulation, and induction of pregnancy in the rat. J Reprod Fertil 1982; 66: 433-443. (Pubitemid 13166531)
28. Musicki B, Burnett AL. eNOS function and dysfunction in the penis. Exp Biol Med 2006; 231: 154-165. (Pubitemid 43213452)
29. Shindel AW, Kishore S, Lue TF. Drugs designed to improve endothelial function: effects on erectile dysfunction. Curr Pharm Des 2008; 14: 3758-3767.
30. Wessells H, Teal TH, Engel K, Sullivan CJ, Gallis B, Tran KB et al. Fluid shear stress-induced nitric oxide production in human cavernosal endothelial cells: inhibition by hyperglycaemia. BJU Int 2006; 97: 1047-1052.
31. Burnett AL. Novel nitric oxide signaling mechanisms regulate the erectile response. Int J Impot Res 2004; 16(Suppl. 1): S15-S19. (Pubitemid 38993078)
32. Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Nat Acad Sci USA 2002; 99: 4061-4066. (Pubitemid 34252229)
33. Musicki B, Champion HC, Becker RE, Liu T, Kramer MF, Burnett AL. Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation. Mol Pharmacol 2005; 68: 226-232. (Pubitemid 41002962)
34. Behr-Roussel D, Gorny D, Mevel K, Caisey S, Bernabé J, Burgess G et al. Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis. Eur Urol 2005; 47: 87-91. (Pubitemid 39575722)
35. Aversa A, Caprio M, Rosano GMC, Spera G. Endothelial effects of drugs designed to treat erectile dysfunction. Curr Pharm Des 2008; 14: 3768-3778.
36. Bivalacqua TJ, Liu TY, Musicki B, Champion HC, Burnett AL. Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. Eur Urol 2007; 51: 1732-1740. (Pubitemid 46634738)
37. Ferrari F, Ottani A, Giuliani D. Influence of sildenafil on central dopamine-medi-ated behaviour in male rats. Life Sci 2002; 70: 1501-1508. (Pubitemid 34164544)